Beckman Coulter Life Sciences has launched its next-generation Basophil Activation Test (BAT), a major advancement for contract research and testing laboratories focusing on food allergy testing. This assay, intended for research use only, offers a transformative alternative to oral food challenges by detecting allergen reactivity through a simple blood draw—eliminating patient exposure risks and reducing testing time.
Utilizing dry reagent technology, the test consolidates allergens and antibodies into a single-tube format, removing many of the procedural complexities traditionally associated with BAT. The format supports standardization and reproducibility—critical for contract labs managing high-throughput workflows across diverse client studies.
Key Benefits for Contract Testing Laboratories
- Safe, non-invasive sample collection—no allergen exposure
- Optimized for high-throughput testing with simplified setup
- Dry technology supports consistent results across batches
- Reduces operational time with only four pipetting steps
- Compatible with existing flow cytometers—no new equipment required
- Supports multiplex testing for multiple allergens in a single run
The new BAT provides a reliable and scalable platform for contract labs to deliver faster, safer, and more cost-effective food allergy testing services.
This article has been sourced from a press release and may include content created or refined using AI tools and verified by our editorial team. For the full press release, visit: “Beckman Coulter Life Sciences Launches Safer, Next-Generation Basophil Activation Test to Improve, Expedite Allergy Research“
